+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Digital Pathology Market by Product, Type, Application, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 189 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 4791773
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Digital Pathology Market grew from USD 1.85 billion in 2023 to USD 2.11 billion in 2024. It is expected to continue growing at a CAGR of 14.58%, reaching USD 4.81 billion by 2030.

Digital pathology refers to the process of converting glass slide-based microscopy images into digital images using scanning technologies. This allows for enhanced analysis and sharing of pathological data, streamlining diagnostics and results interpretation. The necessity of digital pathology lies in its ability to offer improved accuracy, efficiency, and accessibility of pathological assessments, aiding in faster diagnosis and treatment planning, particularly in remote areas where expert pathologists may not be available. Applications include disease diagnosis, drug discovery, and educational purposes. End-use sectors encompass hospitals, diagnostic laboratories, research centers, and academic institutions. The market is significantly influenced by the growing prevalence of chronic diseases, advancements in personalized medicine, and an increasing shift towards automation within healthcare systems.

Key growth factors contributing to the expansion of the digital pathology market include technological advancements in digital imaging, artificial intelligence integration, and increasing governmental support for healthcare IT solutions. Moreover, recent opportunities have emerged, such as collaborations between technology firms and medical institutions to develop cost-effective solutions, and the escalation of telepathology services gaining popularity due to increased demand for remote diagnostics. To leverage these opportunities, businesses should focus on enhancing cloud-based architectures and exploring partnerships for technology advancements.

However, market growth faces challenges including high initial investment costs, regulatory hurdles, and a lack of standardization across platforms. To overcome these barriers, innovation can focus on reducing costs through improved manufacturing processes, developing universally compatible software solutions, and collaborating with regulatory bodies to streamline compliance procedures. Additionally, investing in AI-driven analytics for quick and precise image evaluation presents a lucrative area for research and development. Recognizing the paradigm shift towards digital health, stakeholders could target integrated solutions that combine digital pathology with broader healthcare analytics, thus capitalizing on the digital transformation within the healthcare industry. As the market matures, it is anticipated to become more competitive, prompting a drive for continuous innovation and adaptation.

Understanding Market Dynamics in the Digital Pathology Market

The Digital Pathology Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing prevalence of chronic disease
    • Rising adoption of digital pathology to enhance lab efficiency
    • Increasing penetration of healthcare IT solutions across research
  • Market Restraints
    • High capital investment required for the implementation of digital pathology
  • Market Opportunities
    • Integration of Artificial intelligence and big data analysis to improve the pathologist’s workstation experience
    • Strategic partnership and agreement among companies for the introduction of an effective portfolio
  • Market Challenges
    • Lack of labeled data and legal barriers in digital pathology

Exploring Porter’s Five Forces for the Digital Pathology Market

Porter’s Five Forces framework further strengthens the insights of the Digital Pathology Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Digital Pathology Market

External macro-environmental factors deeply influence the performance of the Digital Pathology Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Digital Pathology Market

The Digital Pathology Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Digital Pathology Market

The Digital Pathology Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Digital Pathology Market

The Digital Pathology Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Digital Pathology Market, highlighting leading vendors and their innovative profiles. These include 3DHISTECH Ltd., Aiforia Technologies PLC, Charles River Laboratories, Corista LLC, DeepBio, Inc., Epredia, F. Hoffmann-La Roche Ltd., FUJIFILM Holdings Corporation, GE Healthcare, Hamamatsu Photonics K.K., Huron Digital Pathology, Indica Labs, Koninklijke Philips N.V., Laboratory Corporation of America Holdings, Leica Biosystems Nussloch GmbH, Mikroscan Technologies, Motic, Nikon Corporation, OptraSCAN, Inc., PathAI, Pathcore Inc., PathPresenter Corporation, PerkinElmer, Inc., Proscia, Inc., Sectra AB, Visiopharm A/S, and Xybion Digital Inc..

Market Segmentation & Coverage

This research report categorizes the Digital Pathology Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Scanners
    • Software
    • Storage Systems
  • Type
    • Human Pathology
    • Veterinary Pathology
  • Application
    • Disease Diagnosis
    • Drug Discovery
    • Education & Training
  • End-User
    • Academic & Research Institutes
    • Hospitals & Laboratories
    • Pharmaceutical & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of chronic disease
5.1.1.2. Rising adoption of digital pathology to enhance lab efficiency
5.1.1.3. Increasing penetration of healthcare IT solutions across research
5.1.2. Restraints
5.1.2.1. High capital investment required for the implementation of digital pathology
5.1.3. Opportunities
5.1.3.1. Integration of Artificial intelligence and big data analysis to improve the pathologist’s workstation experience
5.1.3.2. Strategic partnership and agreement among companies for the introduction of an effective portfolio
5.1.4. Challenges
5.1.4.1. Lack of labeled data and legal barriers in digital pathology
5.2. Market Segmentation Analysis
5.2.1. Product: Growing shift towards cloud-based solutions for more flexible and cost-effective storage options
5.2.2. Application: Rising adoption of digital pathology to enhance the speed and accuracy of identifying potential therapeutic targets and understanding disease mechanisms
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Digital Pathology Market, by Product
6.1. Introduction
6.2. Scanners
6.3. Software
6.4. Storage Systems
7. Digital Pathology Market, by Type
7.1. Introduction
7.2. Human Pathology
7.3. Veterinary Pathology
8. Digital Pathology Market, by Application
8.1. Introduction
8.2. Disease Diagnosis
8.3. Drug Discovery
8.4. Education & Training
9. Digital Pathology Market, by End-User
9.1. Introduction
9.2. Academic & Research Institutes
9.3. Hospitals & Laboratories
9.4. Pharmaceutical & Biotechnology Companies
10. Americas Digital Pathology Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Digital Pathology Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Digital Pathology Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Partnership Between Proscia and Pramana, Inc. Elevates Digital Pathology through Advanced AI and Imaging Technologies
13.3.2. Strategic Alliance Between Ibex Medical Analytics and PathPresenter Enhances AI-Powered Digital Pathology Adoption
13.3.3. Roche Tissue Diagnostics and PathAI Enhances AI-Powered Companion Diagnostics
13.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. DIGITAL PATHOLOGY MARKET RESEARCH PROCESS
FIGURE 2. DIGITAL PATHOLOGY MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 11. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 13. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. DIGITAL PATHOLOGY MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. DIGITAL PATHOLOGY MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. DIGITAL PATHOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. DIGITAL PATHOLOGY MARKET DYNAMICS
TABLE 7. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY SCANNERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY STORAGE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY HUMAN PATHOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY VETERINARY PATHOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY EDUCATION & TRAINING, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY HOSPITALS & LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DIGITAL PATHOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 29. ARGENTINA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 33. BRAZIL DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 34. BRAZIL DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 35. CANADA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 36. CANADA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 37. CANADA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. CANADA DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 39. MEXICO DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 40. MEXICO DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 41. MEXICO DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. MEXICO DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES DIGITAL PATHOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 52. ASIA-PACIFIC DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 53. AUSTRALIA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 54. AUSTRALIA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 55. AUSTRALIA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. AUSTRALIA DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 57. CHINA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 58. CHINA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 59. CHINA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. CHINA DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 61. INDIA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 62. INDIA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 63. INDIA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. INDIA DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 65. INDONESIA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 66. INDONESIA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 67. INDONESIA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. INDONESIA DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. JAPAN DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 70. JAPAN DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 71. JAPAN DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. JAPAN DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 73. MALAYSIA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 74. MALAYSIA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. MALAYSIA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. MALAYSIA DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 77. PHILIPPINES DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 78. PHILIPPINES DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 79. PHILIPPINES DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. PHILIPPINES DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. SINGAPORE DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 82. SINGAPORE DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 83. SINGAPORE DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. SINGAPORE DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 85. SOUTH KOREA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 86. SOUTH KOREA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 87. SOUTH KOREA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. SOUTH KOREA DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 89. TAIWAN DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 90. TAIWAN DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 91. TAIWAN DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. TAIWAN DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. THAILAND DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. THAILAND DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 95. THAILAND DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. THAILAND DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 97. VIETNAM DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 98. VIETNAM DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 99. VIETNAM DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. VIETNAM DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 106. DENMARK DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 107. DENMARK DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 108. DENMARK DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. DENMARK DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 110. EGYPT DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 111. EGYPT DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 112. EGYPT DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. EGYPT DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 114. FINLAND DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 115. FINLAND DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 116. FINLAND DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. FINLAND DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 118. FRANCE DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 119. FRANCE DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 120. FRANCE DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. FRANCE DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 122. GERMANY DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 123. GERMANY DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 124. GERMANY DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. GERMANY DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 126. ISRAEL DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 127. ISRAEL DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 128. ISRAEL DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. ISRAEL DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. ITALY DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 131. ITALY DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 132. ITALY DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. ITALY DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 134. NETHERLANDS DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 136. NETHERLANDS DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. NETHERLANDS DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 138. NIGERIA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 139. NIGERIA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 140. NIGERIA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. NIGERIA DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 142. NORWAY DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 143. NORWAY DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 144. NORWAY DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. NORWAY DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 146. POLAND DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 147. POLAND DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 148. POLAND DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. POLAND DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 150. QATAR DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 151. QATAR DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 152. QATAR DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. QATAR DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. RUSSIA DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 166. SPAIN DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 167. SPAIN DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 168. SPAIN DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. SPAIN DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 170. SWEDEN DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 171. SWEDEN DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 172. SWEDEN DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. SWEDEN DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 174. SWITZERLAND DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 175. SWITZERLAND DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 176. SWITZERLAND DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 177. SWITZERLAND DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 178. TURKEY DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 179. TURKEY DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 180. TURKEY DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. TURKEY DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM DIGITAL PATHOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM DIGITAL PATHOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM DIGITAL PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM DIGITAL PATHOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 190. DIGITAL PATHOLOGY MARKET SHARE, BY KEY PLAYER, 2023
TABLE 191. DIGITAL PATHOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Digital Pathology Market, which are profiled in this report, include:
  • 3DHISTECH Ltd.
  • Aiforia Technologies PLC
  • Charles River Laboratories
  • Corista LLC
  • DeepBio, Inc.
  • Epredia
  • F. Hoffmann-La Roche Ltd.
  • FUJIFILM Holdings Corporation
  • GE Healthcare
  • Hamamatsu Photonics K.K.
  • Huron Digital Pathology
  • Indica Labs
  • Koninklijke Philips N.V.
  • Laboratory Corporation of America Holdings
  • Leica Biosystems Nussloch GmbH
  • Mikroscan Technologies
  • Motic
  • Nikon Corporation
  • OptraSCAN, Inc.
  • PathAI
  • Pathcore Inc.
  • PathPresenter Corporation
  • PerkinElmer, Inc.
  • Proscia, Inc.
  • Sectra AB
  • Visiopharm A/S
  • Xybion Digital Inc.

Methodology

Loading
LOADING...

Table Information